Oral Anticoagulants Market Key Highlights:
- Market Size (2024): USD 16.78 Billion
- Projected Market Size (2034): USD 33.62 Billion
- CAGR (2023-2034): 7.2%
Pricing Analysis:
- Price Growth
- Regional Variations
Market Historic Sales
- Total sales volume, year-over-year growth, product categories, and market share.
Revenue Estimation
- Forecasting future revenues based on historical data, market trends, and economic indicators.
Sales by Region
- Breakdown of sales performance across different geographical areas.
Revenue by Manufacturer
- Analysis of revenue contributions from different manufacturers in the market.
Oral Anticoagulants Market Definition
The oral anticoagulants (DOACs) market revolves around the offering of the pharmaceutical industry focused on the production, and sale of oral drugs, that are used for various aims such as in the prevention and treatment of clot formation. There is a growing demand for oral drugs especially for the treatment of various thromboembolic disorders mainly because of their effectiveness, safety, and ease of use in comparison to conventional anticoagulants such as warfarin.
The oral anticoagulants market is predicted to expand owing to their quick acceptance and use in the thrombus-loading patient groups. The supply of such anticoagulants is ensured by the advancement in the quality of modern anticoagulant therapy, being an option for warfarin. They ensure consistent effectiveness, and fixed dosage irrespective of the monitored level, hence, offer a potential market. An increase in the consumption of these classes of anticoagulants can also be attributed to the rising awareness of the new therapies and the increased demand resulting from a large patient population in developing countries.
Oral Anticoagulants Market Segmentation:
By Type
- Direct Thrombin Inhibitors
- Direct Factor Xa Inhibitors
By Application
- Deep Vein Thrombosis (DVT)
- Pulmonary Embolism
- Acute Coronary Syndrome
- Hemodialysis
- Others
Oral Anticoagulants Market Companies:
- Johnson & Johnson
- Bristol-Myers Squibb
- Boehringer Ingelheim
- Sanofi
- Daiichi Sankyo
- Armatheon
- Aspen
- AstraZeneca
- Bayer
- Cellceutix
- Cosmo Pharmaceuticals
- CSL Behring
- Eisai
- GSK
- Marathon Pharmaceuticals
- Ockham Biotech
- Perosphere.
For any questions about this dataset or to discuss customization options, please write to us at sales@statifacts.com
